TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Laurantis Pharma Oy
Closing information (x1000 DKK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
15
|
7 | |
| Financial expenses |
283
|
29,953
|
730 |
| Earnings before taxes |
-4,602
|
-48,228
|
-12,433 |
| Total assets |
2,119
|
627
|
43,375 |
| Current assets |
1,992
|
500
|
558 |
| Current liabilities |
1,271
|
1,433
|
1,206 |
| Equity capital |
-27,544
|
-23,036
|
25,135 |
| - share capital |
22
|
22
|
22 |
| Employees (average) | 1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
-1299.9%
|
-3674.0%
|
57.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-321520.0%
|
-177614.3% | |
| Return on assets (ROA) |
-203.8%
|
-2914.7%
|
-27.0% |
| Current ratio |
156.7%
|
34.9%
|
46.3% |
| Return on equity (ROE) |
16.7%
|
209.4%
|
-49.5% |
| Change turnover |
7
|
7 | |
| Change turnover % | 100% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.